🚀 VC round data is live in beta, check it out!
Largest HealthTech Public Companies
Benchmark revenue and EBITDA valuation multiples for public comps like
Johnson & Johnson, UnitedHealth Group, Siemens, Thermo Fisher Scientific and Abbott.
 | $234 | +50% | $564B | $592B | 6.2x | 16.5x | ||
| $325 | -21% | $295B | $345B | 0.8x | 12.9x | ||
 | $282 | +21% | $215B | $249B | 2.6x | 14.6x | ||
| $527 | +23% | $196B | $225B | 5.0x | 19.8x | ||
| $97 | -26% | $168B | $173B | 3.8x | 14.2x | ||
| $469 | -9% | $167B | $161B | 15.3x | 35.4x | ||
| $195 | -2% | $138B | $153B | 6.1x | 19.5x | ||
| $343 | -8% | $131B | $143B | 5.6x | 19.4x | ||
| $86 | +2% | $111B | $130B | 3.6x | 12.8x | ||
| $64 | -38% | $95B | $105B | 5.1x | 16.2x | ||
| $45 | -17% | $50B | $48B | 1.7x | 8.7x | ||
| $589 | +36% | $47B | $48B | 10.8x | 30.6x | ||
| $81 | +7% | $47B | $43B | 6.9x | 22.7x | ||
| $362 | -35% | $37B | $46B | 5.7x | 14.4x | ||
| $122 | +13% | $34B | $36B | 5.1x | 17.4x | ||
| $75 | +6% | $34B | $40B | 1.9x | 10.7x | ||
| $22 | -15% | $33B | $32B | 5.8x | 14.9x | ||
| $328 | -6% | $32B | $33B | 8.0x | 23.8x | ||
| $176 | +14% | $30B | $43B | 2.6x | 11.3x | ||
| $208 | +38% | $30B | $29B | 11.9x | (110.2x) | ||
 | $23 | -28% | $28B | $25B | 5.1x | 15.6x | ||
 | $29 | +13% | $28B | $34B | 1.6x | 9.5x | ||
| $168 | -28% | $27B | $21B | 6.4x | 14.1x | ||
| $1,341 | +25% | $27B | $29B | 7.2x | 22.9x | ||
| $64 | -10% | $25B | $24B | 5.0x | 16.9x | ||
| $271 | +12% | $22B | $28B | 2.0x | 11.6x | ||
| $226 | +0% | $22B | $24B | 4.0x | 14.2x | ||
| $222 | -7% | $22B | $24B | 6.7x | 21.9x | ||
| $195 | +9% | $22B | $28B | 2.5x | 12.4x | ||
| $6 | +31% | $20B | $13B | 1.2x | 18.3x | ||
| $104 | +127% | $20B | $21B | — | — | ||
| $95 | -8% | $18B | $25B | 3.0x | 9.2x | ||
 | $20 | +35% | $17B | $14B | 4.2x | 9.9x | ||
| $197 | +38% | $17B | $28B | 1.3x | 6.0x | ||
| $111 | +55% | $15B | $15B | 4.8x | 15.2x | ||
| $520 | +69% | $15B | $14B | 5.5x | 25.1x | ||
 | $245 | -24% | $15B | $14B | 3.0x | 11.4x | ||
 | $17 | +20% | $14B | $17B | 2.7x | 10.5x | ||
| $204 | -19% | $14B | $14B | 5.0x | 20.9x | ||
| $17 | -14% | $14B | $13B | 6.1x | 37.0x | ||
| $190 | +10% | $14B | $13B | 3.1x | 11.4x | ||
 | $22 | +12% | $13B | $13B | 9.5x | 28.1x | ||
 | $107 | -22% | $13B | $13B | 2.6x | 10.4x | ||
| $46 | -11% | $13B | $23B | 1.0x | 5.5x | ||
| $70 | +7% | $12B | $16B | 2.0x | 7.4x | ||
| $90 | +91% | $12B | $12B | 11.6x | (59.2x) | ||
 | $106 | -35% | $11B | $11B | 60.2x | 68.0x | ||
| $10 | -15% | $11B | $11B | 1.8x | 11.1x | ||
 | $11 | -8% | $11B | $11B | 9.8x | 38.7x | ||
| $94 | +1% | $11B | $13B | 4.5x | 15.0x | ||
| $56 | +8% | $10B | $11B | 7.7x | 752.1x | ||
| $1 | -7% | $10B | $8B | 1.6x | 26.1x | ||
| $9 | +45% | $10B | $9B | 13.7x | — | ||
| $4 | +16% | $10B | $13B | 2.1x | 13.0x | ||
| $178 | +11% | $9B | $10B | 6.3x | 20.9x | ||
| $120 | -21% | $9B | $12B | 1.5x | 8.0x | ||
| $41 | -8% | $8B | $9B | 4.3x | 11.9x | ||
| $295 | +22% | $8B | $8B | 3.0x | 17.0x | ||
| $121 | -38% | $8B | $8B | 4.6x | 17.9x | ||
| $149 | -54% | $8B | $3B | 0.1x | 3.9x | ||
| $125 | +32% | $7B | $7B | 13.2x | (405.1x) | ||
| $15 | -21% | $7B | $11B | 1.5x | 8.3x | ||
| $86 | +0% | $7B | $8B | 6.0x | 13.8x | ||
| $115 | -13% | $7B | $8B | 1.1x | 6.6x | ||
| $24 | +4% | $7B | $6B | 1.7x | 10.3x | ||
| $10 | -12% | $7B | $6B | 2.5x | 9.8x | ||
| $29 | -13% | $7B | $7B | 2.9x | 22.3x | ||
| $3 | -8% | $6B | $8B | 3.1x | 11.7x | ||
| $41 | +2% | $6B | $8B | 2.3x | 13.8x | ||
 | $22 | +11% | $6B | $7B | 1.8x | 9.5x | ||
| $174 | +33% | $6B | $6B | 2.1x | 4.9x | ||
| $5 | +33% | $6B | $5B | — | — | ||
| $279 | -14% | $6B | $6B | 7.6x | 27.7x | ||
| $22 | +60% | $6B | $6B | 6.3x | 17.9x | ||
| $132 | -4% | $6B | $8B | 3.9x | 13.8x | ||
| $9 | -46% | $6B | $6B | 1.8x | 8.1x | ||
| $29 | -9% | $6B | $5B | 15.5x | 60.7x | ||
| $1 | +97% | $6B | $5B | 38.5x | (101.1x) | ||
| $132 | +114% | $6B | $5B | 2.2x | 11.1x | ||
| $84 | -20% | $5B | $6B | 3.8x | 10.3x | ||
| $71 | +143% | $5B | $5B | 6.0x | (52.1x) | ||
| $38 | -10% | $5B | $5B | 12.5x | 31.4x | ||
| $7 | -12% | $5B | $5B | 6.9x | 15.9x | ||
| $381 | -15% | $5B | $5B | 5.9x | 13.1x | ||
| $11 | +101% | $5B | $4B | — | — | ||
| $26 | -31% | $5B | $6B | 5.5x | 13.1x | ||
| $20 | +22% | $5B | $6B | 5.8x | 23.3x | ||
| $23 | -28% | $5B | $4B | 0.9x | 8.1x | ||
| $5 | -4% | $5B | $4B | 2.9x | 14.4x | ||
| $16 | +21% | $5B | $2B | 0.2x | (24.5x) | ||
| $60 | +15% | $5B | $6B | 2.7x | 18.3x | ||
| $129 | +8% | $5B | $5B | 4.5x | 19.7x | ||
| $25 | -57% | $5B | $4B | 5.9x | 10.8x | ||
| $28 | +73% | $5B | $5B | 1.8x | 12.9x | ||
| $3 | -9% | $4B | $5B | — | — | ||
| $2 | +47% | $4B | $5B | 4.6x | 15.8x | ||
| $69 | -- | $4B | $6B | 2.9x | 11.6x | ||
| $21 | +23% | $4B | $4B | 0.9x | 33.2x | ||
 | $16 | -26% | $4B | $5B | 3.3x | 12.8x | ||
| $71 | -25% | $4B | $5B | 3.0x | 11.9x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of last 12 months. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.